Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Van Inwegen

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Archives of Biochemistry and Biophysics|January 15, 1977
Characterization of particulate cyclic nucleotide phosphodiesterases of rat kidneyR G Van Inwegen, R L Swafford, S J Strada, et al.
Archives of Biochemistry and Biophysics|August 1, 1976
Characterization of cyclic nucleotide phosphodiesterases with multiple separation techniquesR G Van Inwegen, W J Pledger, S J Strada, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
REV 5901: an orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profileR G Van Inwegen, A Khandwala, R Gordon, et al.
The Journal of Biological Chemistry|July 10, 1974
Effects of thyroid hormone deficiency on cyclic adenosine 3':5'-monophosphate and control of lipolysis in fat cellsK J Armstrong, J E Stouffer, R G Van Inwegen, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1984
Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysisR G Van Inwegen, A Khandwala, I Weinryb, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1986
Mechanistic studies on the "bronchosparing" activity of celiprolol, a cardioselective beta-adrenoceptor antagonistR G Van Inwegen, A Khandwala, R J Gordon, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1986
Celiprolol, a compound possessing weak alpha 2-adrenergic antagonist properties in the dogW S Mann, E F Sales, R G Van Inwegen, et al.
British Journal of Clinical Practice. Supplement|June 1, 1985
Celiprolol--pharmacological profile of an unconventional beta-blockerP S Wolf, R D Smith, A Khandwala, et al.
Agents and Actions|November 1, 1989
The inhibition of 5-lipoxygenase by RG 6866G W Carnathan, D M Sweeney, J J Travis, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Archives of Biochemistry and Biophysics|January 15, 1977
Characterization of particulate cyclic nucleotide phosphodiesterases of rat kidneyR G Van Inwegen, R L Swafford, S J Strada, et al.
Archives of Biochemistry and Biophysics|August 1, 1976
Characterization of cyclic nucleotide phosphodiesterases with multiple separation techniquesR G Van Inwegen, W J Pledger, S J Strada, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
REV 5901: an orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profileR G Van Inwegen, A Khandwala, R Gordon, et al.
The Journal of Biological Chemistry|July 10, 1974
Effects of thyroid hormone deficiency on cyclic adenosine 3':5'-monophosphate and control of lipolysis in fat cellsK J Armstrong, J E Stouffer, R G Van Inwegen, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1984
Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysisR G Van Inwegen, A Khandwala, I Weinryb, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1986
Mechanistic studies on the "bronchosparing" activity of celiprolol, a cardioselective beta-adrenoceptor antagonistR G Van Inwegen, A Khandwala, R J Gordon, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1986
Celiprolol, a compound possessing weak alpha 2-adrenergic antagonist properties in the dogW S Mann, E F Sales, R G Van Inwegen, et al.
British Journal of Clinical Practice. Supplement|June 1, 1985
Celiprolol--pharmacological profile of an unconventional beta-blockerP S Wolf, R D Smith, A Khandwala, et al.
Agents and Actions|November 1, 1989
The inhibition of 5-lipoxygenase by RG 6866G W Carnathan, D M Sweeney, J J Travis, et al.
Pageof 2